Device Trial Radar · NCT06896734
mobiCARE™ ECG Monitoring System
Last checked: Nov 20, 2026Latest source record: May 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
49
Actual
Start
Jan 1, 2025
Primary completion
Feb 5, 2025
Study completion Mar 16, 2025
Sponsor
- Lead sponsor
- Seers Technology Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Eminence Clinical Research, Inc.
- First posted
- Mar 26, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluation of the mobiCARE™ ECG Monitoring System Electrode Placement Positioning Limits in a Prospective, Non-Randomized, Single-Center U.S. Study
Conditions
- ECG Monitoring
Interventions
Evaluation of the ECG signal in the nominal location and in three alternate positionsDevice
Evaluation of the ECG signal in the nominal location and in three alternate positions to determine if the three alternate positions are interpretable.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects in Which the ECG Signal is Interpretable at the Nominal Location and up to 3 Alternate PositionsTime frame: 2 minutes while the patient ambulates
Locations
1 site in 1 country. Site status is shown where the registry gives one.
MCB Clinical Research Centers, LLC
Colorado Springs, Colorado
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.